NewsAI-assisted

SurGenTec's FDA-Approved B-MAN Bone Marrow Aspirate Kit Revolutionizes Cell Extraction

SurGenTec's B-MAN Kit simplifies bone marrow aspiration, offering high-quality, contaminant-free cells.

Mrudula Kulkarni
By Mrudula Kulkarni
Managing Editor - Pharma Now
Aug 26, 2024Updated Jun 26, 2025 · 2 min read
SurGenTec's FDA-Approved B-MAN Bone Marrow Aspirate Kit Revolutionizes Cell Extraction
https://www.surgentec.com/
AI-assisted reporting
Reviewed by Mrudula Kulkarni, Managing Editor - Pharma Now

The B-MAN Bone Marrow Aspirate Kit from SurGenTec, which uses an innovative technique to extract high-quality bone marrow with few impurities, has been approved by the FDA. The kit reduces bone spicules and other contaminants using a centrifuge-free technique and CELLect filtering technology, producing a refined aspirate with improved cell viability. As it optimises cell quality, maintains native cell structure, and makes it easier to extract healthier cells, the B-MAN Kit makes aspiration simpler.

Conventional methods of bone marrow aspiration frequently need centrifuges and several processes, which might be harmful to the integrity of the cells. The B-MAN Kit facilitates the process of obtaining bone marrow by making it simple to use and effective. The kit reduces bone spicule and peripheral blood contamination while increasing the extraction of progenitor cells by optimising marrow contact with a surface area up to three times larger than traditional approaches.

In many surgical applications, such as orthopaedic operations, spinal treatments, and regenerative medicine, bone marrow aspirate is essential. When a patient's own cells are used instead of those from donors or allografts, the danger of disease transmission is greatly reduced. .. Based in Boca Raton, Florida, SurGenTec is a privately held medical device firm that specialises in cutting-edge technology for orthopaedic and neurosurgical spine treatments. It places a high priority on patient safety by offering minimally invasive treatment choices.

TopicsNews
Mrudula Kulkarni
Written by
Mrudula Kulkarni
Managing Editor - Pharma Now

My international experience as a researcher in Taiwan for three years has equipped me with a global perspective, enabling me to create content that resonates with an international audience.



Discussion

Loading discussion…

More from Pharma News

All stories →